Seeking Alpha

Navidea Biopharma signs first Asian distribution agreement

  • Navidea Biopharmaceuticals (NAVB) announces a distribution agreement with
    Global Medical Solutions Taiwan for Lymphoseek.
  • NAVB says the deal builds "on the growth of Lymphoseek sales in the United States, which continue the positive trends recently reported."
  • The company says it will work with its partner to address Taiwanese regulatory requirements and expects "local approval in 2014-15," although Lymphoseek may be available prior to approval "in appropriate situations." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs